Gilead sues Teva over HIV med

Gilead Sciences filed a patent infringement lawsuit against Teva Pharmaceutical Industries over the generic drugmaker's move to make a version of the blockbuster HIV treatment Truvada. Release l Report

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.